miércoles, 2 de octubre de 2019

Cystic Fibrosis News Today Weekly Digest


Cystic Fibrosis Weekly Update

Contents:

Hexoskin Smart Shirt Can Accurately Assess Respiratory Function, May Be Tool in CF, Study Shows

Oct 02, 2019 07:00 am | Alice Melão, MSc



Hexoskin lung functionUsing a simple shirt — a smart one — is closer to becoming a common method to measure lung function in patients with respiratory conditions, including chronic obstructive pulmonary disease (COPD) and cystic fibrosis. A new study conducted by researchers from Radboud University Medical Center and University of Twente, both in the Netherlands, has showed that the […]
The post Hexoskin Smart Shirt Can Accurately Assess Respiratory Function, May Be Tool in CF, Study Shows appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Hexoskin Smart Shirt Can Accurately Assess Respiratory Function, May Be Tool in CF, Study Shows on Facebook

‘I’m Better at Being Sick Than You Are’: Chronic Illness Is Not a Competition

Oct 01, 2019 03:00 pm | Bailey Vincent



competitionChronic illness can feel like a competition. It can become a game of “who has the most badges,” like “minimum pieces of flair” in the movie “Office Space.” Who has the most symptoms and diseases? Who will win? Sometimes, we even post our badges online like identity pieces to our personality. #Anxiety #Gastroparesis #MotilityIssues #SinusInfections […]
The post ‘I’m Better at Being Sick Than You Are’: Chronic Illness Is Not a Competition appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike ‘I’m Better at Being Sick Than You Are’: Chronic Illness Is Not a Competition on Facebook

IL-1 Receptor Inhibition a Potential Strategy to Block Mucus Build-up in Early CF, Study Suggests

Oct 01, 2019 07:00 am | Steve Bryson PhD



mucus build-upInhibition of the interleukin-1 receptor — to block thick mucus production and inflammation — is a potential strategy to treat cystic fibrosis (CF) in the early stages of the disease before harmful chronic bacterial infections, a study suggests.  The study, “IL-1β dominates the promucin secretory cytokine profile in cystic fibrosis,” was published in The Journal […]
The post IL-1 Receptor Inhibition a Potential Strategy to Block Mucus Build-up in Early CF, Study Suggests appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike IL-1 Receptor Inhibition a Potential Strategy to Block Mucus Build-up in Early CF, Study Suggests on Facebook

Recent News

An Obstacle on My Chosen Career Path Led to an Identity Crisis
Public Encouraged to Vote for 2 Students with CF to Receive $22K AbbVie Scholarships
AzurRx BioPharma Announces Promising Results from Trial Testing MS1819 for EPI in CF Patients
NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC
FAQs About Cystic Fibrosis

No hay comentarios:

Publicar un comentario